Pegmolesatide | m-entrepreneurship.com

Product Name :
Pegmolesatide

Search keywords :
Pegmolesatide

drugId :
null

Target Vo:
Erythropoietin receptor

Target Vo Short Name :
EpoR

Moa_Name:
Erythropoiesis stimulants

First Approval Country :
Mainland China

First Approval Date Filter:
2023

Origin Company_Name :
Jiangsu Hansoh Pharmaceutical Group Co Ltd

Active Company_Name :
Jiangsu Hansoh Pharmaceutical Group Co Ltd

Active Indication_Name:
Renal Insufficiency, Chronic

In Active Indication_Name:
Kidney Failure, Chronic

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ki67 Rat mAb Autophagy
Durvalumab PD-1/PD-L1
Carbonic Anhydrase I Antibody: Carbonic Anhydrase I is a non-conjugated and Rabbit origined monoclonal antibody about 29 kDa, targeting to Carbonic Anhydrase I . It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts